This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Velliyagounder, K.
Right arrow Articles by Fine, D. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Velliyagounder, K.
Right arrow Articles by Fine, D. H.

 Previous Article  |  Next Article 

Infection and Immunity, November 2003, p. 6141-6147, Vol. 71, No. 11
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.11.6141-6147.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.

One of Two Human Lactoferrin Variants Exhibits Increased Antibacterial and Transcriptional Activation Activities and Is Associated with Localized Juvenile Periodontitis

Kabilan Velliyagounder,1 Jeffrey B. Kaplan,1 David Furgang,1 Diana Legarda,1,2 Gill Diamond,1 Ruth E. Parkin,3 and Daniel H. Fine1*

Department of Oral Biology,1 Department of Periodontology, New Jersey Dental School,3 and Graduate School of Biomedical Sciences, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 071032

Received 5 May 2003/ Returned for modification 24 June 2003/ Accepted 5 August 2003

The iron-binding protein lactoferrin is a ubiquitous and abundant constituent of human exocrine secretions. Lactoferrin inhibits bacterial growth by sequestering essential iron and also exhibits non-iron-dependent antibacterial, antifungal, antiviral, antitumor, anti-inflammatory, and immunoregulatory activities. All of these non-iron-dependent activities are mediated by the highly charged N terminus of lactoferrin. In this study we characterized a Lys/Arg polymorphism at position 29 in the N-terminal region of human lactoferrin that results from a single nucleotide polymorphism in exon 1 of the human lactoferrin gene. We expressed cDNAs encoding both lactoferrin variants in insect cells and purified the two proteins by ion exchange chromatography. The two lactoferrin variants exhibited nearly identical iron-binding and iron-releasing activities and equivalent bactericidal activities against a strain of the gram-negative bacterium Actinobacillus actinomycetemcomitans. When tested against the gram-positive species Streptococcus mutans and Streptococcus mitis, however, lactoferrin containing Lys at position 29 exhibited significantly greater bactericidal activity than did lactoferrin containing Arg. In addition, the Lys-containing lactoferrin stimulated bovine tracheal epithelial cells to synthesize much higher levels of tracheal antimicrobial peptide mRNA than did the Arg-containing variant. A genotyping assay that distinguished between the two alleles based on a polymorphic EarI restriction site showed that the Lys and Arg alleles had frequencies of 24% and 76%, respectively, among 17 healthy human subjects, and 72% and 28%, respectively, among nine patients with localized juvenile periodontitis. Our findings suggest that these two lactoferrin variants are functionally different and that these differences may contribute to the pathogenesis of localized juvenile periodontitis.


* Corresponding author. Mailing address: Medical Science Building, Room C-636, New Jersey Dental School, 185 S. Orange Ave., Newark, NJ 07103-2714. Phone: (973) 972-7053. Fax: (973) 972-0045. E-mail: finedh{at}umdnj.edu.


Infection and Immunity, November 2003, p. 6141-6147, Vol. 71, No. 11
0019-9567/03/$08.00+0     DOI: 10.1128/IAI.71.11.6141-6147.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Beckloff, N., Laube, D., Castro, T., Furgang, D., Park, S., Perlin, D., Clements, D., Tang, H., Scott, R. W., Tew, G. N., Diamond, G. (2007). Activity of an Antimicrobial Peptide Mimetic against Planktonic and Biofilm Cultures of Oral Pathogens. Antimicrob. Agents Chemother. 51: 4125-4132 [Abstract] [Full Text]  
  • Zarember, K. A., Sugui, J. A., Chang, Y. C., Kwon-Chung, K. J., Gallin, J. I. (2007). Human Polymorphonuclear Leukocytes Inhibit Aspergillus fumigatus Conidial Growth by Lactoferrin-Mediated Iron Depletion. J. Immunol. 178: 6367-6373 [Abstract] [Full Text]  
  • Wakabayashi, H., Takakura, N., Yamauchi, K., Tamura, Y. (2006). Modulation of Immunity-Related Gene Expression in Small Intestines of Mice by Oral Administration of Lactoferrin. CVI 13: 239-245 [Abstract] [Full Text]  
  • Dijkshoorn, L., Brouwer, C. P. J. M., Bogaards, S. J. P., Nemec, A., van den Broek, P. J., Nibbering, P. H. (2004). The Synthetic N-Terminal Peptide of Human Lactoferrin, hLF(1-11), Is Highly Effective against Experimental Infection Caused by Multidrug-Resistant Acinetobacter baumannii. Antimicrob. Agents Chemother. 48: 4919-4921 [Abstract] [Full Text]